Importance of optimizing duration of adjuvant immune checkpoint inhibitor therapy to treat postoperative hepatocellular carcinoma after conversion therapy: a case report

Abstract Patients with hepatocellular carcinoma at high risk of recurrence after hepatic resection or local ablation often undergo adjuvant immunotherapy with immune checkpoint inhibitors for 1 year in randomized controlled trials, but the appropriateness of this duration is controversial, especiall...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Journal of surgical case reports 2023-11, Vol.2023 (11), p.rjad610
Hauptverfasser:	Li, Jian-Rong, Yang, Da-Long, Wang, Jin-Ming, Tian, Wei, Wei, Wei, Luo, Cheng-Piao, Qi, Lu-Nan, Ma, Liang, Zhong, Jian-Hong
Format:	Artikel
Sprache:	eng
Schlagworte:	Case Report
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!